Select a community
All Communities
Home > Community Treatment Reports > Memantine Treatment Report
What is Memantine?

Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. It is also being tested for use as a cognitive enhancer in a variety of other conditions. Read more...Click to read more below

Merz's Memantine site

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 10%
Mild
1 10%
None
8 80%

Most commonly reported side effects

Vivid dreams
1 10%
Metallic taste in mouth
1 10%
  • Mild
  • Moderate
  • Severe

Dosages

  20 mg as needed daily 20 mg weekly 5 mg daily 10 mg daily 15 mg daily 20 mg daily 40 mg daily 100 mg daily 200 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 8 Number of Patients: 8 13 Number of Patients: 13 4 Number of Patients: 4 26 Number of Patients: 26 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Memantine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
8 73% Did not seem to work: 73%
Side effects too severe
2 18% Side effects too severe: 18%
Expense
1 9% Expense: 9%
Personal research
1 9% Personal research: 9%
Other
1 9% Other: 9%

See all 11 patients who’ve stopped taking Memantine

Currently Taking Memantine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
4
11
6
11

Stopped Taking Memantine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
4
0
2
2
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
9 90%
Usually
1 10%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
3 30%
Not at all
7 70%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 10%
$50-99
2 20%
$25-49
3 30%
< $25
1 10%

Report created on November 21, 2009.